Vaccines have transformed public health, protecting people around the world against a range of infectious diseases. By protecting individuals, whole communities can benefit from the dramatic reduction and even elimination […]
ACCESS TO NEW VACCINES
Vaccines are widely regarded as one of the most important public health intervention available. In the last decade, several new vaccines have completed the development process and received approval from […]
FACTS & FIGURES
EVM regularly publishes brochures to present facts and figures on the European-based vaccine industry but also on key issues. _The contribution of the vaccine industry to Europe’s health and welfare […]
EU REGULATORY FRAMEWORK FOR VACCINES
The vaccine industry is highly regulated. Vaccine development is a complex and time-consuming process. On average it takes 12 to 15 years to develop a new vaccine. Before a new […]
HOT TOPICS
H1N1 Influenza Pandemic In June 2009, WHO declared the first influenza pandemic in 40 years. This decision was motivated by the outbreaks of A/H1N1 influenza virus at community-level and the […]
impfstoffenwicklungvomlabor
Développement de Vaccins : Du Laboratoire au Marché et Au-delà Le processus d’évaluation en cours des vaccins après leur mise sur le marché ou leur approbation par les autorités demeure […]